KR890008148A - 새로운 세파로스포린 화합물 및 항균제 - Google Patents
새로운 세파로스포린 화합물 및 항균제 Download PDFInfo
- Publication number
- KR890008148A KR890008148A KR1019880012096A KR880012096A KR890008148A KR 890008148 A KR890008148 A KR 890008148A KR 1019880012096 A KR1019880012096 A KR 1019880012096A KR 880012096 A KR880012096 A KR 880012096A KR 890008148 A KR890008148 A KR 890008148A
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- lower alkyl
- new
- group
- sepharoseporin
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 4
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 230000000269 nucleophilic effect Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229930186147 Cephalosporin Natural products 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 229940124587 cephalosporin Drugs 0.000 claims 1
- -1 cephalosporin compound Chemical class 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (2)
- 다음식으로 나타낸 새로운 세파로스포린 화합물 및 그약리상 허용되는 염.위식에서 R1, R2는 같거나 다른 수소원자 또는 탄소수 1-5의 저급알킬기, R3는 탄소수 1-5의 저급알킬기로 할로겐 원자를 함유하며, 또는 알케닐기, 또는 탄소수 3-6의 시클로알킬메틸기, A는 수소원자 또는 구핵성화합물잔기이다.
- 다음식으로 나타낸 새로운 세파로스포린화합물 및 그약기상 허용되는 염을 유효성분으로 함유하는 항균제.위식에서 R1, R2는 같거나 다른 수소원자 또는 탄소수 1-5의 저급알킬기, R3는 탄소수 1-5의 저급알킬기로 할로겐 원자를 함유하며, 또는 알케닐기, 또는 탄소수 3-6의 시클로알킬메틸기, A는 수소원자 또는 구핵성 화합물잔기이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62284634A JPH0633281B2 (ja) | 1987-11-11 | 1987-11-11 | 新規セファロスポリン化合物及び抗菌剤 |
JP???62-284634 | 1987-11-11 | ||
JP?62-284634 | 1987-11-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890008148A true KR890008148A (ko) | 1989-07-10 |
KR970005844B1 KR970005844B1 (ko) | 1997-04-21 |
Family
ID=17681012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880012096A KR970005844B1 (ko) | 1987-11-11 | 1988-09-19 | 새로운 세파로스포린 화합물 및 항균제 |
Country Status (5)
Country | Link |
---|---|
US (1) | US4971961A (ko) |
EP (1) | EP0315997B1 (ko) |
JP (1) | JPH0633281B2 (ko) |
KR (1) | KR970005844B1 (ko) |
DE (1) | DE3889198T2 (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028601A (en) * | 1987-04-30 | 1991-07-02 | Meiji Saika Kaisha, Ltd. | Cephalosporin compounds and antibacterial agents |
JPH0248580A (ja) * | 1988-08-10 | 1990-02-19 | Meiji Seika Kaisha Ltd | 新規セファロスポリン系化合物及び抗菌剤 |
WO1992002523A1 (en) * | 1990-08-02 | 1992-02-20 | Sankei Pharmaceutical Company Limited | Novel cephalosporin compound |
EP0544958A1 (en) * | 1990-08-09 | 1993-06-09 | Tanabe Seiyaku Co., Ltd. | Cephalosporin compounds and processes for preparing the same |
WO2001034579A1 (fr) * | 1999-11-10 | 2001-05-17 | Takeda Chemical Industries, Ltd. | Derives d'acide alcoxyiminoalcanoique |
US20110118462A1 (en) * | 2009-11-18 | 2011-05-19 | Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory | N-heterocyclic substituent-containing antibiotic, preparation and use thereof |
KR101716985B1 (ko) * | 2015-12-24 | 2017-03-16 | 현대다이모스(주) | 차량용 시트레일 록킹장치 |
CN110655526A (zh) * | 2018-06-28 | 2020-01-07 | 中国科学院上海药物研究所 | 头孢菌素-铁载体轭合物及其制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ215527A (en) * | 1985-04-01 | 1989-06-28 | Mochida Pharm Co Ltd | Cephalosporin derivatives and pharmaceutical compositions |
US4822786A (en) * | 1986-07-01 | 1989-04-18 | Kaken Pharmaceutical Co., Ltd. | Cephalosporin compounds, and antibacterial agents |
US5028601A (en) * | 1987-04-30 | 1991-07-02 | Meiji Saika Kaisha, Ltd. | Cephalosporin compounds and antibacterial agents |
-
1987
- 1987-11-11 JP JP62284634A patent/JPH0633281B2/ja not_active Expired - Lifetime
-
1988
- 1988-09-19 KR KR1019880012096A patent/KR970005844B1/ko not_active IP Right Cessation
- 1988-11-02 US US07/266,050 patent/US4971961A/en not_active Expired - Lifetime
- 1988-11-10 EP EP88118769A patent/EP0315997B1/en not_active Expired - Lifetime
- 1988-11-10 DE DE3889198T patent/DE3889198T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0315997A2 (en) | 1989-05-17 |
JPH01125384A (ja) | 1989-05-17 |
DE3889198T2 (de) | 1994-11-24 |
EP0315997B1 (en) | 1994-04-20 |
JPH0633281B2 (ja) | 1994-05-02 |
DE3889198D1 (de) | 1994-05-26 |
KR970005844B1 (ko) | 1997-04-21 |
EP0315997A3 (en) | 1990-11-28 |
US4971961A (en) | 1990-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950000728A (ko) | 포스포네이트 뉴클레오티드 에스테르 유도체 | |
DE3271269D1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
KR900006296A (ko) | 이미다졸린 유도체 및 그의 제조방법 | |
KR960007592A (ko) | 신규한 피롤로카바졸 | |
KR930016402A (ko) | 항-hiv 활성을 갖는 이미다졸 유도체 | |
KR930703292A (ko) | 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 | |
KR890008148A (ko) | 새로운 세파로스포린 화합물 및 항균제 | |
KR950702530A (ko) | 프로스타글란딘 유도체 | |
KR900016178A (ko) | 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
KR900003177A (ko) | 테트라시클릭계 우울증 치료제 | |
KR860003247A (ko) | 티아디아진 화합물 및 그 염의 제조방법 | |
KR960700245A (ko) | 메토트렉세이트 유도체[methotrexate derivative] | |
KR850000455A (ko) | 세팔로스포린 에스테르 유도체의 제조방법 | |
KR890009901A (ko) | 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용 | |
KR900006316A (ko) | 벤조 헤테로 고리화합물 및 그 제조방법 | |
KR960703843A (ko) | 아실페닐글리신 유도체 및 그 화합물을 유효성분으로 하는, 콜라게나제 활성증진에 기인한 질환의 예방 및 치료 제(acylphenylglycine derivative and preventive and remedy for diseases caused by increased collagenase activity containing said compound as active ingredient) | |
DK0420224T3 (da) | Anthihepatopatisk middel | |
KR930702339A (ko) | 에폭시숙시남산 유도체 | |
KR850005228A (ko) | 살균제인 아미노알칸포스폰산 및 그 유도체 | |
KR890003718A (ko) | N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제 | |
FI853866A0 (fi) | 2-pyridin-tiol-derivat, foerfarande foer framstaellning av dessa samt farmaceutiska foereningar innehaollande dessa. | |
DE3269533D1 (en) | New quinolylacetic acid compounds and pharmaceutical compositions containing them | |
KR950000705A (ko) | 14-치환 몰피난 유도체 및 이를 함유하는 의약 | |
KR920008012A (ko) | 트리아졸 유도체 | |
KR840008012A (ko) | 아미노에틸-피리딘 및 -피라진유도체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030414 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |